David E Anderson
Chief Scientific Officer VBI Vaccines & HDT Bio
Seminars
Thursday 19th February 2026
Advancing the Use of Cancer Vaccines in Glioblastoma to Reprogram the Patient’s Immune System
4:30 pm
- Discussing the importance of tumor antigen selection and balanced immunity in vaccine design
- Addressing the tumor microenvironment to enhance cancer vaccines
